E Acebo

Summary

Country: Spain

Publications

  1. ncbi Merkel cell carcinoma: a clinicopathological study of 11 cases
    E Acebo
    Department of Dermatology, Hospital de Cruces, Barcaldo, Vizcaya, Spain
    J Eur Acad Dermatol Venereol 19:546-51. 2005
  2. ncbi Congenital hemangioma: a report of evolution from rapidly involuting to noninvoluting congenital hemangioma with aberrant Mongolian spots
    Elvira Acebo
    Department of Dermatology, Hospital de Cruces, Baracaldo Vizcaya, Spain
    Pediatr Dermatol 26:225-6. 2009
  3. ncbi Cutaneous reactive angiomatosis associated with chronic lymphoid leukemia
    Elvira Acebo Mariñas
    Department of Dermatology, Hospital de Cruces, Plaza de Cruces s n, 48903 Baracaldo, Vizcaya, Spain
    Am J Dermatopathol 30:604-7. 2008
  4. ncbi [Necrobiosis lipoidica over appendectomy scar in a patient with morphea of the breast]
    Elvira Acebo
    Servicio de Dermatologia, Hospital de Cruces, Baracaldo, Bilbao, Spain
    Actas Dermosifiliogr 97:52-5. 2006
  5. ncbi [Eruptive pseudoangiomatosis: study of 7 cases]
    S Pérez-Barrio
    Servicio de Dermatologia, Hospital de Cruces, Baracaldo, Vizcaya, Espana
    Actas Dermosifiliogr 98:178-82. 2007
  6. ncbi [Yellowish plaques on the trunk and in the axillary folds]
    Izaskun Trébol
    Departamento de Dermatologia, Hospital de Cruces, Pl de Cruces s n, 48903 Barakaldo, Vizcaya, Spain
    Actas Dermosifiliogr 96:124-6. 2005
  7. ncbi [Treatment of cutaneous T-cell lymphomas with bexarotene]
    Olatz Lasa
    Servicio de Dermatologia, Hospital de Cruces, Bilbao, Spain
    Actas Dermosifiliogr 96:669-73. 2005
  8. ncbi [Acneiform eruption from epidermal growth factor receptor inhibitors]
    Zuriñe Martínez de Lagrán
    Servicio de Dermatologia, Hospital de Cruces, Bilbao, Spain
    Actas Dermosifiliogr 96:450-4. 2005
  9. ncbi Cutaneous metastases of hepatocellular carcinoma
    M Lazaro
    Department of Dermatology, Cruces Hospital, Bizkaia, Spain
    Clin Exp Dermatol 34:e567-9. 2009
  10. ncbi Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
    Y Peñate
    Department of Dermatology, Complejo Hospitalario Universitario Insular Materno Infantil, Gran Canaria, Las Palmas de GC, Spain
    Br J Dermatol 167:174-9. 2012

Collaborators

Detail Information

Publications10

  1. ncbi Merkel cell carcinoma: a clinicopathological study of 11 cases
    E Acebo
    Department of Dermatology, Hospital de Cruces, Barcaldo, Vizcaya, Spain
    J Eur Acad Dermatol Venereol 19:546-51. 2005
    ..To report our 12-year experience with Merkel cell carcinomas (MCCs) from a clinical and pathological point of view...
  2. ncbi Congenital hemangioma: a report of evolution from rapidly involuting to noninvoluting congenital hemangioma with aberrant Mongolian spots
    Elvira Acebo
    Department of Dermatology, Hospital de Cruces, Baracaldo Vizcaya, Spain
    Pediatr Dermatol 26:225-6. 2009
    ..He also had aberrant, persistent Mongolian spots on both legs. To our knowledge, this association has not been reported to date...
  3. ncbi Cutaneous reactive angiomatosis associated with chronic lymphoid leukemia
    Elvira Acebo Mariñas
    Department of Dermatology, Hospital de Cruces, Plaza de Cruces s n, 48903 Baracaldo, Vizcaya, Spain
    Am J Dermatopathol 30:604-7. 2008
    ..To our knowledge, this is the first case of cutaneous reactive angiomatosis with documented histopathological findings of clinical involution...
  4. ncbi [Necrobiosis lipoidica over appendectomy scar in a patient with morphea of the breast]
    Elvira Acebo
    Servicio de Dermatologia, Hospital de Cruces, Baracaldo, Bilbao, Spain
    Actas Dermosifiliogr 97:52-5. 2006
    ..Necrobiosis lipoidica over surgical scars is infrequently found in the literature. We review the published cases and discuss the association of necrobiosis lipoidica with morphea...
  5. ncbi [Eruptive pseudoangiomatosis: study of 7 cases]
    S Pérez-Barrio
    Servicio de Dermatologia, Hospital de Cruces, Baracaldo, Vizcaya, Espana
    Actas Dermosifiliogr 98:178-82. 2007
    ..It overlaps with the entity known in Japan as <<erythema punctatum Higuchi>>, possibly caused by an insect named Culex pipiens pallens...
  6. ncbi [Yellowish plaques on the trunk and in the axillary folds]
    Izaskun Trébol
    Departamento de Dermatologia, Hospital de Cruces, Pl de Cruces s n, 48903 Barakaldo, Vizcaya, Spain
    Actas Dermosifiliogr 96:124-6. 2005
  7. ncbi [Treatment of cutaneous T-cell lymphomas with bexarotene]
    Olatz Lasa
    Servicio de Dermatologia, Hospital de Cruces, Bilbao, Spain
    Actas Dermosifiliogr 96:669-73. 2005
    ..Bexarotene is an X receptor-specific retinoid with anti-tumor activity. Its use as treatment for CTCLs refractory to at least one prior systemic therapy has been approved by the FDA...
  8. ncbi [Acneiform eruption from epidermal growth factor receptor inhibitors]
    Zuriñe Martínez de Lagrán
    Servicio de Dermatologia, Hospital de Cruces, Bilbao, Spain
    Actas Dermosifiliogr 96:450-4. 2005
    ..We present three cases of acneiform eruptions attributable to different drugs in this family (cetuximab, gefitinib and erlotinib)...
  9. ncbi Cutaneous metastases of hepatocellular carcinoma
    M Lazaro
    Department of Dermatology, Cruces Hospital, Bizkaia, Spain
    Clin Exp Dermatol 34:e567-9. 2009
    ..A case of cutaneous metastases of hepatocellular carcinoma, which may often involve other organs but very rarely metastases to the skin, is reported...
  10. ncbi Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
    Y Peñate
    Department of Dermatology, Complejo Hospitalario Universitario Insular Materno Infantil, Gran Canaria, Las Palmas de GC, Spain
    Br J Dermatol 167:174-9. 2012
    ..The effectiveness of intralesional rituximab (ILR) in primary cutaneous B-cell lymphomas (PCBL) has been described in a small number of patients...